Mix No
A µg.ml
-1
PLS
PCR
AD µg.ml
-1
PLS
PCR
G µg.ml
-1
PLS
PCR
GD µg.ml
-1
PLS
PCR
1
7.50
99.29
99.40
2.40
98.85
98.95
40.00
102.51
102.15
12.00
98.57
98.58
2
9.00
99.44
99.46
3.00
95.90
95.76
45.00
99.03
99.05
9.00
100.74
101.07
3
6.75
99.10
98.87
2.70
99.62
99.69
55.00
101.50
102.04
12.00
96.99
96.49
4
6.75
101.91
101.83
3.30
101.32
101.38
60.00
100.93
101.08
11.00
100.81
100.72
5
7.50
100.18
100.25
3.60
100.22
100.29
60.00
98.24
98.03
8.00
106.21
106.56
6
6.00
101.01
100.78
3.00
101.47
101.30
55.00
100.77
101.22
11.00
99.40
99.59
7
8.25
100.76
100.79
3.30
99.81
100.12
45.00
99.60
99.50
8.00
100.85
100.09
8
8.25
101.7
101.74
2.70
100.72
100.97
40.00
99.39
99.23
9.00
101.12
100.77
Mean
100.42
100.39
99.74
99.81
100.25
100.29
100.59
100.48
R.S.D.%
1.093
1.094
1.782
1.833
1.419
1.531
2.684
2.877
Table 2:
Results of the analysis of the mixtures of the validation set of Ambroxol HCl, Ambroxol HCl degradate, Guaifenesin and Guaicol by the proposed PLS and PCR models.
